Logo image of JEN.DE

JENOPTIK AG (JEN.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:JEN - DE000A2NB601 - Common Stock

22.4 EUR
+0.18 (+0.81%)
Last: 1/16/2026, 7:00:00 PM
Fundamental Rating

5

Taking everything into account, JEN scores 5 out of 10 in our fundamental rating. JEN was compared to 52 industry peers in the Electronic Equipment, Instruments & Components industry. JEN has only an average score on both its financial health and profitability. JEN has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • JEN had positive earnings in the past year.
  • JEN had a positive operating cash flow in the past year.
  • In the past 5 years JEN has always been profitable.
  • Each year in the past 5 years JEN had a positive operating cash flow.
JEN.DE Yearly Net Income VS EBIT VS OCF VS FCFJEN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

1.2 Ratios

  • JEN has a Return On Assets of 4.37%. This is in the better half of the industry: JEN outperforms 72.73% of its industry peers.
  • JEN has a better Return On Equity (7.45%) than 65.45% of its industry peers.
  • JEN has a better Return On Invested Capital (6.01%) than 67.27% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for JEN is in line with the industry average of 7.60%.
Industry RankSector Rank
ROA 4.37%
ROE 7.45%
ROIC 6.01%
ROA(3y)4.32%
ROA(5y)4.15%
ROE(3y)8.12%
ROE(5y)8.24%
ROIC(3y)7.15%
ROIC(5y)6.58%
JEN.DE Yearly ROA, ROE, ROICJEN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10

1.3 Margins

  • Looking at the Profit Margin, with a value of 6.89%, JEN is in the better half of the industry, outperforming 78.18% of the companies in the same industry.
  • In the last couple of years the Profit Margin of JEN has remained more or less at the same level.
  • With an excellent Operating Margin value of 10.91%, JEN belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
  • JEN's Operating Margin has improved in the last couple of years.
  • The Gross Margin of JEN (31.95%) is worse than 69.09% of its industry peers.
  • JEN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.91%
PM (TTM) 6.89%
GM 31.95%
OM growth 3Y-1.94%
OM growth 5Y5.73%
PM growth 3Y-8.73%
PM growth 5Y0.97%
GM growth 3Y0.54%
GM growth 5Y0.38%
JEN.DE Yearly Profit, Operating, Gross MarginsJEN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), JEN is creating some value.
  • JEN has about the same amout of shares outstanding than it did 1 year ago.
  • JEN has about the same amout of shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, JEN has an improved debt to assets ratio.
JEN.DE Yearly Shares OutstandingJEN.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
JEN.DE Yearly Total Debt VS Total AssetsJEN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • JEN has an Altman-Z score of 2.66. This is not the best score and indicates that JEN is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of JEN (2.66) is comparable to the rest of the industry.
  • JEN has a debt to FCF ratio of 4.56. This is a neutral value as JEN would need 4.56 years to pay back of all of its debts.
  • JEN has a better Debt to FCF ratio (4.56) than 61.82% of its industry peers.
  • A Debt/Equity ratio of 0.30 indicates that JEN is not too dependend on debt financing.
  • JEN has a Debt to Equity ratio (0.30) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 4.56
Altman-Z 2.66
ROIC/WACC0.94
WACC6.38%
JEN.DE Yearly LT Debt VS Equity VS FCFJEN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

  • JEN has a Current Ratio of 1.56. This is a normal value and indicates that JEN is financially healthy and should not expect problems in meeting its short term obligations.
  • JEN's Current ratio of 1.56 is in line compared to the rest of the industry. JEN outperforms 43.64% of its industry peers.
  • JEN has a Quick Ratio of 1.56. This is a bad value and indicates that JEN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.78, JEN is doing worse than 74.55% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.56
Quick Ratio 0.78
JEN.DE Yearly Current Assets VS Current LiabilitesJEN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

3

3. Growth

3.1 Past

  • The earnings per share for JEN have decreased strongly by -14.86% in the last year.
  • The Earnings Per Share has been growing slightly by 6.54% on average over the past years.
  • The Revenue has decreased by -5.27% in the past year.
  • Measured over the past years, JEN shows a small growth in Revenue. The Revenue has been growing by 5.46% on average per year.
EPS 1Y (TTM)-14.86%
EPS 3Y4.03%
EPS 5Y6.54%
EPS Q2Q%-19.57%
Revenue 1Y (TTM)-5.27%
Revenue growth 3Y14.12%
Revenue growth 5Y5.46%
Sales Q2Q%-7.1%

3.2 Future

  • Based on estimates for the next years, JEN will show a small growth in Earnings Per Share. The EPS will grow by 7.51% on average per year.
  • The Revenue is expected to grow by 3.76% on average over the next years.
EPS Next Y-18.05%
EPS Next 2Y2.85%
EPS Next 3Y7.3%
EPS Next 5Y7.51%
Revenue Next Year-5.05%
Revenue Next 2Y0.66%
Revenue Next 3Y2.51%
Revenue Next 5Y3.76%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
JEN.DE Yearly Revenue VS EstimatesJEN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B
JEN.DE Yearly EPS VS EstimatesJEN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2

5

4. Valuation

4.1 Price/Earnings Ratio

  • JEN is valuated rather expensively with a Price/Earnings ratio of 17.78.
  • JEN's Price/Earnings ratio is a bit cheaper when compared to the industry. JEN is cheaper than 78.18% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.38, JEN is valued a bit cheaper.
  • With a Price/Forward Earnings ratio of 13.07, JEN is valued correctly.
  • Based on the Price/Forward Earnings ratio, JEN is valued a bit cheaper than the industry average as 65.45% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.29, JEN is valued a bit cheaper.
Industry RankSector Rank
PE 17.78
Fwd PE 13.07
JEN.DE Price Earnings VS Forward Price EarningsJEN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, JEN is valued a bit cheaper than 69.09% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, JEN is valued a bit cheaper than the industry average as 67.27% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 13.93
EV/EBITDA 8.48
JEN.DE Per share dataJEN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The decent profitability rating of JEN may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.72
EPS Next 2Y2.85%
EPS Next 3Y7.3%

4

5. Dividend

5.1 Amount

  • JEN has a Yearly Dividend Yield of 1.71%. Purely for dividend investing, there may be better candidates out there.
  • JEN's Dividend Yield is a higher than the industry average which is at 1.54.
  • Compared to an average S&P500 Dividend Yield of 1.85, JEN has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.71%

5.2 History

Dividend Growth(5Y)0%
Div Incr Years0
Div Non Decr Years0
JEN.DE Yearly Dividends per shareJEN.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2025 0.1 0.2 0.3

5.3 Sustainability

  • JEN pays out 29.95% of its income as dividend. This is a sustainable payout ratio.
DP29.95%
EPS Next 2Y2.85%
EPS Next 3Y7.3%
JEN.DE Yearly Income VS Free CF VS DividendJEN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
JEN.DE Dividend Payout.JEN.DE Dividend Payout, showing the Payout Ratio.JEN.DE Dividend Payout.PayoutRetained Earnings

JENOPTIK AG

FRA:JEN (1/16/2026, 7:00:00 PM)

22.4

+0.18 (+0.81%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-12
Earnings (Next)02-13
Inst Owners44.99%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.28B
Revenue(TTM)1.05B
Net Income(TTM)72.61M
Analysts81.25
Price Target25.2 (12.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.71%
Yearly Dividend0.35
Dividend Growth(5Y)0%
DP29.95%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-6.92%
Min EPS beat(2)-7.96%
Max EPS beat(2)-5.88%
EPS beat(4)1
Avg EPS beat(4)-7.55%
Min EPS beat(4)-20.99%
Max EPS beat(4)4.63%
EPS beat(8)3
Avg EPS beat(8)-5.97%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.26%
Min Revenue beat(2)-5.74%
Max Revenue beat(2)-2.79%
Revenue beat(4)0
Avg Revenue beat(4)-3.45%
Min Revenue beat(4)-5.74%
Max Revenue beat(4)-1.93%
Revenue beat(8)1
Avg Revenue beat(8)-6.46%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)2.26%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.12%
EPS NY rev (1m)-0.13%
EPS NY rev (3m)-2.18%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.74%
Valuation
Industry RankSector Rank
PE 17.78
Fwd PE 13.07
P/S 1.22
P/FCF 13.93
P/OCF 7.29
P/B 1.32
P/tB 4.23
EV/EBITDA 8.48
EPS(TTM)1.26
EY5.63%
EPS(NY)1.71
Fwd EY7.65%
FCF(TTM)1.61
FCFY7.18%
OCF(TTM)3.07
OCFY13.72%
SpS18.41
BVpS17.03
TBVpS5.29
PEG (NY)N/A
PEG (5Y)2.72
Graham Number21.97
Profitability
Industry RankSector Rank
ROA 4.37%
ROE 7.45%
ROCE 8.76%
ROIC 6.01%
ROICexc 6.3%
ROICexgc 13.58%
OM 10.91%
PM (TTM) 6.89%
GM 31.95%
FCFM 8.73%
ROA(3y)4.32%
ROA(5y)4.15%
ROE(3y)8.12%
ROE(5y)8.24%
ROIC(3y)7.15%
ROIC(5y)6.58%
ROICexc(3y)7.54%
ROICexc(5y)6.96%
ROICexgc(3y)16.1%
ROICexgc(5y)15.71%
ROCE(3y)10.41%
ROCE(5y)9.58%
ROICexgc growth 3Y-2.02%
ROICexgc growth 5Y2.07%
ROICexc growth 3Y7.18%
ROICexc growth 5Y-3.9%
OM growth 3Y-1.94%
OM growth 5Y5.73%
PM growth 3Y-8.73%
PM growth 5Y0.97%
GM growth 3Y0.54%
GM growth 5Y0.38%
F-Score4
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 4.56
Debt/EBITDA 1.51
Cap/Depr 107.82%
Cap/Sales 7.96%
Interest Coverage 8.16
Cash Conversion 91.27%
Profit Quality 126.78%
Current Ratio 1.56
Quick Ratio 0.78
Altman-Z 2.66
F-Score4
WACC6.38%
ROIC/WACC0.94
Cap/Depr(3y)121.37%
Cap/Depr(5y)106.88%
Cap/Sales(3y)8.22%
Cap/Sales(5y)7.57%
Profit Quality(3y)101.44%
Profit Quality(5y)95.78%
High Growth Momentum
Growth
EPS 1Y (TTM)-14.86%
EPS 3Y4.03%
EPS 5Y6.54%
EPS Q2Q%-19.57%
EPS Next Y-18.05%
EPS Next 2Y2.85%
EPS Next 3Y7.3%
EPS Next 5Y7.51%
Revenue 1Y (TTM)-5.27%
Revenue growth 3Y14.12%
Revenue growth 5Y5.46%
Sales Q2Q%-7.1%
Revenue Next Year-5.05%
Revenue Next 2Y0.66%
Revenue Next 3Y2.51%
Revenue Next 5Y3.76%
EBIT growth 1Y-19.47%
EBIT growth 3Y11.91%
EBIT growth 5Y11.51%
EBIT Next Year33.26%
EBIT Next 3Y19.98%
EBIT Next 5Y14.54%
FCF growth 1Y28.17%
FCF growth 3Y12.68%
FCF growth 5Y2.87%
OCF growth 1Y14.61%
OCF growth 3Y19.51%
OCF growth 5Y8.88%

JENOPTIK AG / JEN.DE FAQ

What is the fundamental rating for JEN stock?

ChartMill assigns a fundamental rating of 5 / 10 to JEN.DE.


What is the valuation status for JEN stock?

ChartMill assigns a valuation rating of 5 / 10 to JENOPTIK AG (JEN.DE). This can be considered as Fairly Valued.


How profitable is JENOPTIK AG (JEN.DE) stock?

JENOPTIK AG (JEN.DE) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for JEN stock?

The Price/Earnings (PE) ratio for JENOPTIK AG (JEN.DE) is 17.78 and the Price/Book (PB) ratio is 1.32.


How financially healthy is JENOPTIK AG?

The financial health rating of JENOPTIK AG (JEN.DE) is 4 / 10.